Price (delayed)
$8.76
Market cap
$622.76M
P/E Ratio
9.22
Dividend/share
N/A
EPS
$0.95
Enterprise value
$472.62M
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies
There are no recent dividends present for SIGA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.